CDC42 and cancer: Even when Rac and Cdc42 are not overexpressed or mutated in cancer, they can be activated by a myriad of oncogenic cell surface receptors and guanine nucleotide exchange factors (GEFs) that exchange the GDP on inactive Rac/Cdc42 for a GTP.